Violent attacks are increasing in the last mile for pharmaceutical supply chain distribution. These suggested guidelines offer companies seeking to strengthen their in-transit security program a directed approach to reducing risk.

Guidance is provided on analyzing distribution methods in the last mile of the pharmaceutical supply chain and implementing controls to counter emerging threats to the industry.